ZYXI - צמיחת הכנסות ב-12 חודשים נגררים Zynex Corp

Zynex, Inc. (ZYXI) implements high-tech wearable electrical stimulation systems to combat chronic pain without opioids. The LTM sales volume trend demonstrates a peak in development, after which the current parameter equals -44.10. Device assembly relies on external suppliers for circuit boards and plastics. Profit stability is ensured by direct sales of NexWave and steady demand for disposable electrodes.
zynex.com (ZYXI) - פילוחי מדדים ודוחות פיננסיים

Year-over-year (LTM) gross revenue dynamics clearly demonstrate the market expansion of Zynex, Inc. (ZYXI) within the home electrotherapy segment. This indicator captures the percentage change in total revenue over a rolling year relative to the preceding period. The calculation is based on a comparison of total sales over 365 days, which neutralizes seasonality and strips noise from the data. For a mature business, such a trajectory confirms the resilience of demand for opioid alternatives. It is critical for investors to correlate this growth with margins to avoid overpaying for the asset.